These clinical results were better than the group of surgiral therapy only (15–20%) [83]. COSS-80 study investigated the effectiveness of use of adjuvant chemotherapy with IFN
These clinical results were better than thegroup of surgiral therapy only (15–20%) [83]. COSS-80 studyinvestigated the effectiveness of use of adjuvant chemotherapywith IFN